Kirt Tyson N.M.D
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
- Testosterone Replacement Therapy (TRT)
- Hormone Replacement Therapy (HRT)
- NAD IV Therapy
Washington, DC
NAD+ IV therapy in Washington is offered at integrative and anti-aging clinics, often alongside peptide programs and broader IV menus. Hospital-grade infusion pathways run through MedStar Washington Hospital Center, GW Hospital, and Howard University Hospital, but NAD+ itself is strictly cash-pay. Demand reflects a federal-workforce, diplomatic, and high-income professional population.
NAD+ is a cellular cofactor marketed for energy, longevity, addiction recovery, and neurological symptoms. Evidence for IV NAD+ is preliminary, and the FDA has not approved NAD+ for any indication. Infusions in Washington, District of Columbia typically run 250 to 1,000 mg over several hours and cost 400 to 1,000 dollars per session. DC Board of Medicine scope and strict compounding rules shapes compounding and prescribing authority.
With NAD+ clinics on Regenerated.com in Washington, patients can compare compounding source, physician oversight, and whether a clinic honestly frames NAD+ as investigational rather than a cure.
Regulatory context
FDA regulates the compounded ingredients used in IV therapy and the facilities that prepare them. Patient-specific compounded IVs fall under FDCA Section 503A, while bulk preparations for office use fall under Section 503B (outsourcing facilities). USP Chapter 797 governs sterile compounding standards. FDA has issued warnings about injectable glutathione marketed for skin lightening (2017) and has not approved NAD IV for any specific indication. Vitamin and mineral IV mixtures such as the Myers cocktail are compounded preparations and are not FDA-approved drug products.
The District of Columbia medical and nursing boards have addressed unlicensed practice in medical spa and IV lounge settings. Common enforcement themes include IV therapy administered without a valid physician order, stale or missing standing orders, absence of a designated medical director, and unlicensed personnel performing venipuncture. Boards have reiterated that a prescribing physician or APRN must establish a bona fide patient relationship before any IV protocol is initiated, and that standing orders must be specific, dated, and periodically reviewed.